Stallion India

Who are the top shareholders of the Stallion India?

The top shareholder of Stallion India is Shazad Sheriar Rustomji, holding 67.88% of the shares. Other shareholders include 12 Foreign Institutional Investors with 3.32%, Geetu Yadav as the highest public shareholder at 4.16%, and individual investors holding 16.94%, with no pledged promoter holdings or mutual funds involved.

The top shareholders of Stallion India are primarily the promoters, with Shazad Sheriar Rustomji holding the largest share at 67.88%. In addition to the promoters, there are 12 Foreign Institutional Investors (FIIs) collectively holding 3.32% of the company. The highest public shareholder is Geetu Yadav, who owns 4.16%. Individual investors account for 16.94% of the total shareholding. Notably, there are no pledged promoter holdings and no mutual funds currently holding shares in the company.

Has Stallion India declared dividend?

No Dividend History Available

Who are the peers of the Stallion India?

Stallion India's peers include Solar Industries, Linde India, PCBL Chemical, Refex Industries, Prem. Explosives, DIC India, Keltech Energies, Beezaasan Exp., and Natl. Oxygen. Key insights show varying management risks, growth rates, and capital structures among these companies, with Refex Industries leading in 1-year returns at 270.26% and Linde India having the lowest at -15.03%.

Peers: The peers of Stallion India are Solar Industries, Linde India, PCBL Chemical, Refex Industries, Prem. Explosives, DIC India, Keltech Energies, Beezaasan Exp., and Natl. Oxygen.<BR><BR>Quality Snapshot: Excellent management risk is observed at Solar Industries, while Good management risk is found at Linde India and PCBL Chemical, and Average management risk is present at Refex Industries, Prem. Explosives, Stallion India, DIC India, Keltech Energies, and Beezaasan Exp. Excellent growth is seen at Solar Industries, PCBL Chemical, and Refex Industries, while Good growth is noted at Prem. Explosives and Beezaasan Exp., Average growth is found at Keltech Energies, and Below Average growth is present at Linde India and DIC India. Excellent capital structure is attributed to Solar Industries, Refex Industries, and Stallion India, while Average capital structure is seen at PCBL Chemical, and Good capital structure is noted at DIC India and Keltech Energies, with Below Average capital structure at Prem. Explosives and Natl. Oxygen.<BR><BR>Return Snapshot: Refex Industries has the highest 1-year return at 270.26%, while Linde India has the lowest at -15.03%. Stallion India's 1-year return is not available for comparison. Additionally, Linde India and DIC India have negative six-month returns.

What does Stallion India do?

Stallion India Fluorochemicals Ltd, a Micro Cap company established in 2002, operates in the Other Chemical products industry and reported net sales of 1,516 Cr and a net profit of 133 Cr for the quarter ending March 2025. The company has a market cap of INR 823 Cr and a P/E ratio of 25.00.

Overview: <BR>Stallion India Fluorochemicals Ltd operates in the Other Chemical products industry and is categorized as a Micro Cap company.<BR><BR>History: <BR>The company was incorporated in 2002 as a Private Limited Company in Mumbai and later converted to a Public Limited Company, with the name changed to Stallion India Fluorochemicals Limited on October 05, 2023. The most recent quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 1,516 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 133 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 823 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 25.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.24 <BR>Return on Equity: 10.75% <BR>Price to Book: 2.65 <BR><BR>Contact Details: <BR>No Company Details Available <BR>Registrar Address: Not available.

How big is Stallion India?

As of 24th July, Stallion India Fluorochemicals Ltd has a market capitalization of 929.00 Cr, with recent net sales of 304.28 Cr and a net profit of 23.91 Cr. The company's shareholder's funds are 117.96 Cr, and total assets amount to 202.40 Cr.

As of 24th July, Stallion India Fluorochemicals Ltd has a market capitalization of 929.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Stallion India reported Net Sales of 304.28 Cr and a Net Profit of 23.91 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 117.96 Cr and Total Assets of 202.40 Cr.

When is the next results date for Stallion India?

The next results date for Stallion India is 08 August 2025.

The next results date for Stallion India is scheduled for 08 August 2025.

How has been the historical performance of Stallion India?

Stallion India has shown significant growth over the past three years, with net sales increasing from 225.50 Cr in Mar'23 to 377.45 Cr in Mar'25, and profit after tax rising from 9.75 Cr to 32.33 Cr, reflecting strong operational efficiency and profitability. Total assets also grew substantially, indicating robust financial performance across key metrics.

Answer:<BR>The historical performance of Stallion India shows significant growth in various financial metrics over the past three years.<BR><BR>Breakdown:<BR>Stallion India's net sales increased from 225.50 Cr in Mar'23 to 377.45 Cr in Mar'25, indicating a strong upward trend. Total operating income followed suit, rising from 225.50 Cr in Mar'23 to 377.45 Cr in Mar'25. The company's total expenditure also grew, from 210.46 Cr in Mar'23 to 329.73 Cr in Mar'25, primarily driven by raw material costs, which surged from 195.58 Cr to 292.95 Cr during the same period. Operating profit (PBDIT) saw a substantial rise from 15.60 Cr in Mar'23 to 49.74 Cr in Mar'25, reflecting improved operational efficiency. Profit before tax increased from 12.97 Cr to 42.43 Cr, while profit after tax rose from 9.75 Cr to 32.33 Cr, showcasing a robust growth in profitability. The earnings per share (EPS) also improved significantly, from 1.77 in Mar'23 to 4.08 in Mar'25. On the balance sheet, total assets grew from 125.43 Cr in Mar'23 to 327.21 Cr in Mar'25, with total liabilities increasing from 125.43 Cr to 327.21 Cr as well. The cash flow from financing activities remained positive, contributing to a net cash inflow of 42.00 Cr in Mar'25, up from 15.00 Cr in Mar'24. Overall, Stallion India has demonstrated a strong financial performance with consistent growth across key metrics.

Is Stallion India overvalued or undervalued?

As of November 26, 2025, Stallion India is considered overvalued with a PE ratio of 45.93, an EV to EBITDA of 29.40, and a PEG ratio of 0.00, significantly higher than its peers and has underperformed against the Sensex with a 1-month return of -41.72%.

As of 26 November 2025, Stallion India has moved from a valuation grade of very expensive to expensive. The company is currently considered overvalued. Key ratios include a PE ratio of 45.93, an EV to EBITDA of 29.40, and a ROCE of 19.73%. <BR><BR>In comparison to its peers, Stallion India's PE ratio is significantly higher than Godrej Industries, which stands at 36.8, and Deepak Nitrite at 40.22. The PEG ratio for Stallion is 0.00, indicating no growth expectations priced into the stock, which is concerning given its high valuation. Additionally, Stallion India has underperformed against the Sensex, with a 1-month return of -41.72% compared to the Sensex's 1.66% return, further reinforcing the notion that the stock may be overvalued.

Should I buy, sell or hold Stallion India Fluorochemicals Ltd?

Which are the latest news on Stallion India?

Why is Stallion India Fluorochemicals Ltd falling/rising?

As of 31-Mar, Stallion India Fluorochemicals Ltd's stock price is Rs 102.00, down 3.45%, and has underperformed its sector. The stock has declined significantly over various time frames, with a year-to-date drop of 49.07%, indicating a bearish trend despite some positive fundamentals.

As of 31-Mar, Stallion India Fluorochemicals Ltd's stock price is falling, currently at Rs 102.00, reflecting a decrease of Rs 3.65 or 3.45%. The stock has underperformed its sector by 1.19% today and has experienced a consecutive decline over the last two days, with a total drop of 7.61% in this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.<BR><BR>In the broader context, the stock has seen significant declines over various time frames, with a 1-week drop of 6.51% and a 1-month decline of 19.24%. Year-to-date, the stock has fallen by 49.07%, while the benchmark Sensex has only decreased by 15.57% in the same period. This stark contrast highlights the stock's underperformance relative to the market.<BR><BR>Despite some positive factors, such as a low debt-to-equity ratio and healthy long-term growth in operating profit, the stock's valuation appears expensive with a Price to Book Value of 3.7. Furthermore, while institutional investor participation has increased, suggesting some confidence in the company's fundamentals, the overall market sentiment and recent performance have contributed to the stock's decline.